Fresenius Medical Care AG
FMCQF
$47.20
-$1.18-2.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.94% | -2.60% | -2.32% | 1.67% | 5.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.94% | -2.60% | -2.32% | 1.67% | 5.18% |
| Cost of Revenue | 3.81% | -1.53% | -1.88% | 1.11% | 1.79% |
| Gross Profit | -6.80% | -5.81% | -3.65% | 3.39% | 15.54% |
| SG&A Expenses | -1.64% | -3.78% | -1.60% | 0.39% | 10.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 51.63% | -362.18% | -406.30% | -355.05% | -165.65% |
| Total Operating Expenses | 3.06% | -3.58% | -2.78% | 0.44% | 2.66% |
| Operating Income | -18.33% | 9.72% | 3.43% | 19.29% | 35.21% |
| Income Before Tax | -48.30% | 63.20% | 21.58% | -10.43% | 30.67% |
| Income Tax Expenses | -30.14% | 33.08% | 20.67% | -10.14% | 9.71% |
| Earnings from Continuing Operations | -54.42% | 81.32% | 21.96% | -10.52% | 39.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 26.15% | 17.91% | 3.24% | -0.94% | -32.09% |
| Net Income | -64.75% | 155.09% | 31.76% | -16.83% | 42.65% |
| EBIT | -18.33% | 9.72% | 3.43% | 19.29% | 35.21% |
| EBITDA | -14.78% | 2.46% | -15.27% | 18.82% | 21.72% |
| EPS Basic | -64.76% | 155.10% | 31.76% | -16.83% | 42.64% |
| Normalized Basic EPS | -10.34% | 30.82% | 2.12% | 34.76% | 48.98% |
| EPS Diluted | -65.97% | 155.10% | 31.76% | -16.24% | 42.53% |
| Normalized Diluted EPS | -10.34% | 30.82% | 2.12% | 34.76% | 48.98% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | 19.82% | -- | -- | -- | 11.95% |
| Payout Ratio | -- | -- | -0.20% | -- | -- |
